ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,086.37
0.61%
Dow Jones
44,156.73
0.30%
US Dollar vs MXN
20.4988
-0.02%
Brent Oil
78.385
0.06%
Bitcoin
101,933.68
-1.64%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Cue Biopharma Inc (CUE) Cotización

Cue Biopharma Inc

Cue Biopharma Inc (CUE)

Cue Energy Resources Limited
1.22
0.01
(0.83%)
Cerrado 22 Enero 3:00PM
Delayed by 15 minutes
1.22
0.00
( 0.00% )
Pre Mercado: 3:00AM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
1.22
Postura de Compra
0.98
Postura de Venta
1.41
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.45 Rango de 52 semanas 2.93
Capitalización de Mercado [m]
77.287M
Precio Anterior
1.22
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
472,511
Acciones en circulación
63,350,327
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.52
Beneficio por acción (BPA)
-0.8
turnover
5.49M
Beneficio neto
-50.73M

Acerca de Cue Biopharma Inc

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant ... Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.cuebiopharma.com
Sede
Wilmington, Delaware, USA
Fundado
-
Cue Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CUE. The last closing price for Cue Biopharma was US$1.22. Over the last year, Cue Biopharma shares have traded in a share price range of US$ 0.45 to US$ 2.93.

Cue Biopharma currently has 63,350,327 shares in issue. The market capitalisation of Cue Biopharma is US$77.29 million. Cue Biopharma has a price to earnings ratio (PE ratio) of -1.52.

CUE Últimas noticias

Más noticias

Form 4 - Statement of changes in beneficial ownership of securities

03 Enero 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

03 Enero 2025
Edgar (US Regulatory)

Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively...

29 Noviembre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

29 Noviembre 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

29 Noviembre 2024
Edgar (US Regulatory)

Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference

BOSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage...

25 Noviembre 2024
GlobeNewswire Inc.

Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights

BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage...

14 Noviembre 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

14 Noviembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

14 Noviembre 2024
Edgar (US Regulatory)

Cue Biopharma Announces Strategic Organizational Transition

Daniel Baker, M.D., will join Cue Biopharma’s executive team as interim chief development officer (CDO), effective Monday, November 25, 2024Anish Suri, Ph.D., president & chief scientific...

14 Noviembre 2024
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.09-6.870229007631.311.361.1113456911.24612751CS
40.1918.44660194171.031.750.954195851.34279198CS
12-0.5-29.06976744191.721.98910.924725111.32819361CS
260.4456.41025641030.781.98910.455767651.15945971CS
52-1.67-57.7854671282.892.930.454497241.34029155CS
156-7.39-85.83042973298.6111.230.453619602.81204539CS
260-13.94-91.952506596315.1635.50.453404527.54165802CS

CUE - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Cue Biopharma?
El precio actual de las acciones de Cue Biopharma es US$ 1.22
¿Cuántas acciones de Cue Biopharma están en circulación?
Cue Biopharma tiene 63,350,327 acciones en circulación
¿Cuál es la capitalización de mercado de Cue Biopharma?
La capitalización de mercado de Cue Biopharma es USD 77.29M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Cue Biopharma?
Cue Biopharma ha negociado en un rango de US$ 0.45 a US$ 2.93 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Cue Biopharma?
El ratio precio/beneficio de Cue Biopharma es -1.52
¿Cuál es el ratio de efectivo a ventas de Cue Biopharma?
El ratio de efectivo a ventas de Cue Biopharma es 14.07
¿Cuál es la moneda de reporte de Cue Biopharma?
Cue Biopharma presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Cue Biopharma?
El último ingresos anual de Cue Biopharma es USD 5.49M
¿Cuál es el último beneficio anual de Cue Biopharma?
El último beneficio anual de Cue Biopharma es USD -50.73M
¿Cuál es la dirección registrada de Cue Biopharma?
La dirección registrada de Cue Biopharma es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Cue Biopharma?
La dirección del sitio web de Cue Biopharma es www.cuebiopharma.com
¿En qué sector industrial opera Cue Biopharma?
Cue Biopharma opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
DGNXDiginex Ltd
 20.49
(173.20%)
164.53k
FBNCFirst Bancorp
US$ 67.00
(52.62%)
205
KOPNKopin Corporation
US$ 2.035
(38.44%)
3.98M
XCURExicure Inc
US$ 14.10
(35.97%)
20.07k
TLSATiziana Life Sciences Ltd
US$ 0.987
(23.85%)
697.06k
CPBICentral Plains Bancshares Inc
US$ 10.01
(-31.67%)
4
TSBKTimberland Bancorp Inc
US$ 21.01
(-27.63%)
4
XNCRXencor Inc
US$ 15.01
(-27.38%)
1
UBFOUnited Security Bancshares
US$ 7.21
(-27.25%)
15
NAMSNewAmsterdam Pharma Company NV
US$ 17.01
(-27.21%)
2
KOPNKopin Corporation
US$ 2.035
(38.44%)
3.98M
HEPAHepion Pharmaceuticals Inc
US$ 0.1525
(12.96%)
2.81M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.3397
(6.49%)
2.18M
ASSTAsset Entities Inc
US$ 1.63
(19.85%)
2.16M
SHViShares Short Treasury Bond ETF
US$ 110.38
(0.02%)
1.63M

CUE Discussion

Ver más
boston127 boston127 2 semanas hace
Send URL for the funds loading info.

I also bought today and last week, but am RED because I bought at a higher price.
👍️0
Hawkeye_tt Hawkeye_tt 2 semanas hace
You can easily see when a Fund is loading for the day.
I backed up the truck in the 50 cent dip area. That was a gift.
GL all.....be patient.

Hawk
👍️0
boston127 boston127 2 semanas hace
Today's volume was heavier than usual,

trading 1,209,308 shares, versus an average of 459,032 shares per day during the last twelve months. The On Balance Volume indicator (OBV) shows that longer term selling pressure has given way to near term accumulation by traders.
👍️0
boston127 boston127 2 semanas hace
Momentum for CUE is strongly bullish.

The 14-period Slow Stochastic Oscillator is rising, as investors pay higher prices for shares. Good day today. Got back in recently. Will continue adding all the way to $3.
👍️0
boston127 boston127 2 semanas hace
Thanks. Interesting perspective.

As long as the company is doing well, I can wait and suffer through any dips.
👍️0
Hawkeye_tt Hawkeye_tt 3 semanas hace
This could be Over $5 right now...IMO. Algos/shorts walked this down for mths.
LT looks very good IMO.

Hawk
👍️0
boston127 boston127 3 semanas hace
Great day on Friday.

Wondering if profit taking will follow suit this week.
👍️0
Hawkeye_tt Hawkeye_tt 3 semanas hace
2025 should be a very good yr. New Partnerships and more.

Hawk
👍️0
glenn1919 glenn1919 3 semanas hace
cue.........................https://stockcharts.com/h-sc/ui?s=cue&p=W&b=5&g=0&id=p86431144783
👍️0
Hawkeye_tt Hawkeye_tt 3 meses hace
TY for that quick dip/Algo dump op. Took advantage big time.
GL all...

Hawk
👍️0
boston127 boston127 3 meses hace
Momentum for CUE is waning,

as measured by a 14-period Slow Stochastic Oscillator. This means that investors are less aggressive in their recent purchases and may even be taking profits in positions bought at lower prices.
👍️0
boston127 boston127 4 meses hace
The On Balance Volume indicator (OBV) is bullish.

The slope of the indicator is positive and suggests that buyers are presently more active than sellers.Today's volume was heavier than usual, trading 2,320,021 shares, versus an average of 389,835 shares per day during the last twelve months.
👍️0
boston127 boston127 4 meses hace
Momentum for CUE is strongly bullish.

The 14-period Slow Stochastic oscillator is above 80, the level which many analysts call overbought. This means that investors have been actively purchasing shares and driving the price higher.
👍️0
boston127 boston127 4 meses hace
I got in on Friday. Everything

about the company is good. Gotta love it. They did not give up much to get that $11M in financing. Will buy on dips. Bought a little more today.
👍️0
Monksdream Monksdream 4 meses hace
CUE under $2
👍️0
Hawkeye_tt Hawkeye_tt 4 meses hace
Look at that Wkly candle ! Vol fantastic.
LT outlook back on !

Hawk
👍️0
Triple nickle Triple nickle 4 meses hace
CUE ready to win 1.02
👍️0
Hawkeye_tt Hawkeye_tt 4 meses hace
Strong recovery on news....future looking good here. Buy, hold LT...
Hawk
👍️0
Monksdream Monksdream 7 meses hace
CUE new 52 week low
👍️0
Hawkeye_tt Hawkeye_tt 2 años hace
CUE....this story grows quickly. Merck early investor.
Last few wks it has been breaking out.
$5 break next. More Partners want in, on top of Ono.

Hawk
👍️0
conix conix 3 años hace
CUE Insider Buy
Cue Biopharma Aaron G.L. Fletcher Director Buy 735,000 shares @ $4.76 $3,498,600.00 3/31/2022
👍️0

Su Consulta Reciente

NASDAQ
CUE
Cue Biopharma
ASX
TUL
Tulla Resources
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados